IRIS
SOTA, JURGEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.496
EU - Europa 5.042
AS - Asia 3.367
SA - Sud America 801
AF - Africa 103
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.825
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.408
RU - Federazione Russa 1.482
SG - Singapore 1.130
GB - Regno Unito 1.102
CN - Cina 1.055
IT - Italia 758
BR - Brasile 672
IE - Irlanda 523
HK - Hong Kong 294
SE - Svezia 266
KR - Corea 248
VN - Vietnam 219
DE - Germania 209
UA - Ucraina 171
FR - Francia 167
FI - Finlandia 124
IN - India 101
TR - Turchia 72
AR - Argentina 50
NL - Olanda 44
MX - Messico 39
CA - Canada 37
PL - Polonia 35
BD - Bangladesh 32
JP - Giappone 32
IQ - Iraq 31
PK - Pakistan 29
ES - Italia 28
AT - Austria 27
EC - Ecuador 26
BE - Belgio 25
CI - Costa d'Avorio 21
CZ - Repubblica Ceca 21
ZA - Sudafrica 21
ID - Indonesia 18
AU - Australia 15
IR - Iran 15
MA - Marocco 15
SA - Arabia Saudita 12
CO - Colombia 11
EG - Egitto 11
KE - Kenya 11
NP - Nepal 10
UZ - Uzbekistan 10
VE - Venezuela 10
PE - Perù 9
TN - Tunisia 8
CL - Cile 7
LB - Libano 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
JO - Giordania 6
LT - Lituania 6
CH - Svizzera 5
IL - Israele 5
PY - Paraguay 5
RO - Romania 5
UY - Uruguay 5
AM - Armenia 4
BO - Bolivia 4
DK - Danimarca 4
EE - Estonia 4
LV - Lettonia 4
RS - Serbia 4
TH - Thailandia 4
AL - Albania 3
BH - Bahrain 3
BY - Bielorussia 3
HU - Ungheria 3
JM - Giamaica 3
MY - Malesia 3
NO - Norvegia 3
PS - Palestinian Territory 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
TM - Turkmenistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GI - Gibilterra 1
HN - Honduras 1
Totale 14.813
Salva come PNG Salva come JPEG
Città #
Dallas 1.179
Southend 965
Singapore 723
Dublin 513
Santa Clara 432
Moscow 415
Fairfield 405
Ashburn 367
Hefei 313
Hong Kong 289
Beijing 251
Seoul 248
Woodbridge 227
Siena 189
Chandler 178
Menlo Park 176
Houston 169
Wilmington 153
Ann Arbor 150
Seattle 141
Cambridge 138
New York 136
Jacksonville 134
Los Angeles 99
Milan 97
Princeton 85
Munich 82
The Dalles 69
Ho Chi Minh City 63
Dearborn 60
São Paulo 60
Helsinki 59
Rome 53
Bengaluru 51
Dong Ket 49
Redondo Beach 45
Nanjing 43
San Mateo 42
Buffalo 41
Chicago 37
Lappeenranta 37
Hanoi 33
Nuremberg 29
Lauterbourg 27
Boardman 26
Florence 26
San Diego 26
Shanghai 26
Guangzhou 25
Warsaw 24
Brussels 23
Izmir 23
Tokyo 23
London 22
Abidjan 21
Columbus 21
Turku 20
Portsmouth 19
Düsseldorf 18
Rio de Janeiro 18
Brooklyn 17
Denver 17
Istanbul 17
Council Bluffs 16
Mexico City 16
Nanchang 16
Orem 16
San Francisco 15
Atlanta 14
Belo Horizonte 13
Campinas 13
Jinan 13
Boston 12
Hebei 12
Montreal 12
Shenyang 12
Washington 12
Da Nang 11
Jiaxing 11
Johannesburg 11
Manchester 11
Phoenix 11
Stockholm 11
Ankara 10
Kunming 10
Nairobi 10
Olomouc 10
Poplar 10
Vienna 10
Amsterdam 9
Curitiba 9
Frankfurt am Main 9
Guayaquil 9
Kraków 9
Lahore 9
Sydney 9
Taizhou 9
Tashkent 9
Baghdad 8
Brasília 8
Totale 9.879
Salva come PNG Salva come JPEG
Nome #
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 330
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 313
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 300
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 299
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 297
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 294
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 286
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 264
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 252
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 249
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 239
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 231
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 226
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 223
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 221
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 220
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 219
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 214
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 208
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 206
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 200
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 195
IL-6 blockade in the management of non-infectious uveitis 192
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 183
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 181
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 178
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 177
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 174
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 167
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 161
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 158
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 157
Development and implementation of the AIDA International Registry for patients with Behçet's disease 152
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 152
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 152
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 149
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 145
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 143
Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International Network Registries on ocular inflammatory disorders 140
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 136
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 133
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 131
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 130
Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review 128
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 128
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 127
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 126
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry 126
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 124
Comparing biologic options for the management of Behcet's disease-related uveitis 123
Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study 122
Biotechnological agents for patients with tumor necrosis factor receptor associated periodic syndrome—therapeutic outcome and predictors of response: real-life data from the AIDA Network 121
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 121
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 120
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 114
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 113
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry 113
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema 113
Musculoskeletal manifestations in hereditary periodic fever syndromes 112
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 111
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 111
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 110
The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe 109
Efficacy and safety of adalimumab in pediatric non-infectious non-anterior uveitis: real-life experience from the International AIDA Network Uveitis Registry 109
The current status of biological treatment for uveitis 109
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry 108
Efficacy and safety of abatacept in a patient with rheumatoid arthritis and concomitant Staphylococcus aureus osteomyelitis 108
Development and implementation of the international AIDA network spondylarthritis registry 104
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 104
Development and implementation of the AIDA international registry for patients with Still's disease 103
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 102
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network 102
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 101
Autoinflammatory diseases and the kidney 100
Power and spectral Doppler ultrasound in suspected active sacroiliitis: A comparison with magnetic resonance imaging as gold standard 98
Biologic therapies and small molecules for the management of non-infectious scleritis: a narrative review 98
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 98
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 97
Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 92
New potential weapons for refractory scleritis in the era of targeted therapy 92
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries 91
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 91
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry 90
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 90
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 89
The role of biologic agents in the management of pediatric-onset noninfectious posterior scleritis 88
Polidistrectual videocapillaroscopic evaluation in a patient with prolidase deficiency 87
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA network registries 86
Efficacy and safety of tocilizumab in adult-onset Still's disease: real-life experience from the international AIDA registry 85
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 85
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 84
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 81
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 81
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis 73
Empowering patients in the therapeutic decision-making process: a glance into Behçet's syndrome 71
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: a multicenter study from the AIDA Network PFAPA syndrome registry 71
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 68
The autoinflammatory diseases alliance registry of monogenic autoinflammatory diseases 68
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry 67
Therapeutic approach to central nervous system involvement of Behçet's disease 67
Totale 14.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.542
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021779 0 0 0 0 0 197 63 167 74 116 43 119
2021/2022822 72 112 64 55 45 9 36 32 47 78 104 168
2022/2023804 57 71 132 94 57 153 28 63 72 12 37 28
2023/20241.062 39 24 91 56 32 298 302 55 12 18 48 87
2024/20253.577 289 145 354 151 406 209 164 200 272 183 318 886
2025/20265.593 645 1.233 1.057 1.111 1.439 108 0 0 0 0 0 0
Totale 15.247